However, our study discovered a novel mechanism for inhibiting tumor metastasis with ezetimibe: inhibiting the migration and invasion of triple‐negative breast cancer cells by suppressing TGFβ2 expression. The gene discussed is TGFB2; the disease is neoplasm.